{
  "id": 5058402,
  "title": "Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?",
  "url": "https://urgent.news/2026/09/02/argenx-has-delivered-18-consecutive-quarters-of-sales-growth-but-is-5058402",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-02T09:04:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/argenx-has-delivered-18-consecutive-quarters-sales-growth-biotech-stock-still-underrated"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsArgenx's top and bottom lines are growing robustly.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?",
        "url": "https://urgent.news/2026/09/02/argenx-has-delivered-18-consecutive-quarters-of-sales-growth-but-is",
        "published": "2026-09-02T08:44:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}